Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 255 - Carboxylic acid nitriles
Patents for C07C 255 - Carboxylic acid nitriles (27,066)
11/2005
11/15/2005US6965050 Single crystalline phase catalyst
11/15/2005US6965046 Complex of catalytic oxides of iron, bismuth, molybdenum, cobalt, cerium, antimony, at least one of nickel or magnesium, and at least one of lithium, sodium, potassium, rubidium, or thallium
11/15/2005CA2387517C Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005105744A1 Histamine-3 receptor antagonists
11/10/2005WO2005105733A1 Ortho substituted aryl or heteroaryl amide compounds
11/10/2005WO2005105730A2 Method of preparing an alcohol from a halogenoaromatic compound and an aldehyde
11/10/2005WO2005105727A1 Crth2 receptor antagonists
11/10/2005US20050250959 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/10/2005US20050250822 Substituted benzanilide compound and noxious organism controlling agent
11/10/2005US20050250818 Ortho substituted aryl or heteroaryl amide compounds
11/10/2005US20050250744 Pharmaceutically active compounds and methods of use thereof
11/10/2005US20050247624 extractiing chlorides of zinc and/or iron, from cyanation reaction mixtures of reactants and catalyst systems comprising acid catalysts and complexes; reuse
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/10/2005CA2563454A1 Crth2 receptor antagonists
11/09/2005EP1592659A2 Method of producing dinitrile compounds
11/09/2005EP1100788B1 Substituted quinazoline derivatives
11/09/2005CN1694869A Substituted spirocyclic ketoenols
11/09/2005CN1694864A N-bridged selective androgen receptor modulators and methods of use thereof
11/09/2005CN1226282C Process for preparation of 3-hydroxyacrylonitrile metal salts
11/09/2005CN1226281C Ethanol ammoxidizing process to synthesize high-purity acetonitrile
11/09/2005CN1226280C Method for producing acrylonitrile, catalyst for use therein and method for preparing same
11/09/2005CN1226277C Phenacylamine derivatives, production thereof and pest controllers containing the derivatives
11/09/2005CN1226250C Anthracene derivatives and organic electroluminescent device made by using the same
11/08/2005US6963011 Central nervous system disorders; psychological disorders
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6962995 Phenanthroline derivatives
11/08/2005US6962994 Beta hydroxy ketone is treated with a trialkylborane or dialkylalkoxyborane or a mixture of a trialkylborane and a dialkylalkoxyborane followed by recovery and reuse of the alkylborane species
11/03/2005WO2005102990A1 Androgen modulators
11/03/2005WO2005102989A1 Non-nucleoside reverse transcriptase inhibitors
11/03/2005WO2005102388A1 Novel blt2-mediated disease, and blt2 binding agent and compound
11/03/2005WO2005080316A3 Modulators of cannabinoid receptors
11/03/2005US20050245761 Single crystalline phase catalyst
11/03/2005US20050245615 Treating proliferative cutaneous disease using a polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; e.g. lupus; use with other biosynthesis enzyme inhibitors
11/03/2005US20050245602 Selective estrogen receptor modulators
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/03/2005DE4000535B4 1,4-Disubstituierte 2,6-Difluorbenzolverbindungen und flüssigkristallines Medium 1,4-Disubstituted 2,6-Difluorbenzolverbindungen and liquid crystalline medium
11/03/2005CA2563180A1 Non-nucleoside reverse transcriptase inhibitors
11/02/2005EP1591161A1 Method for producing metal oxide catalyst
11/02/2005EP1591117A1 Breast cancer resistance protein (bcrp) inhibitor
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590320A1 Process for recovering acrylonitrile or methacrylonitrile
11/02/2005EP1590319A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
11/02/2005EP1590318A2 Modulators (inhibitors/activators) of histone acetyltransferases
11/02/2005EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments
11/02/2005EP1140842B1 Alkyl esters of 3-(3,4-dihalogenophenyl)-2,6-dioxopiperidine-3-propionic acid useful as intermediates
11/01/2005US6960680 reacting 1,2-epoxides with inorganic cyanides, aqueous organic solvent with acidic buffer which aids by-product inhibition; lighter color to 3-hydroxyvaleronitrile distillate oil; easy isolation by distillation/ filtration; industrial scale
11/01/2005US6960581 1-amino-2-hydroxy-butane or 2-hydroxy-butanamide derivatives
10/2005
10/27/2005WO2005100325A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors
10/27/2005WO2005100323A1 Process for preparing pyridazinone compounds
10/27/2005WO2005100305A1 Androgen modulators
10/27/2005WO2005100304A1 Adamantane derivative and process for producing the same
10/27/2005WO2005100297A1 Indene derivatives and process for the preparation thereof
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050239881 viricides; polymerase inhibitors; therapy for genetic engineered virus
10/27/2005US20050239879 Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl) ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester
10/27/2005US20050239849 Substituted phenoxyacetic acids
10/27/2005US20050239839 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
10/27/2005US20050239828 Spirocyclic amides as cannabinoid receptor modulators
10/27/2005US20050239802 E.g., 6-{2-[5-Chloro-2-(2,4-difluorobenzyloxy)- phenyl]cyclopent-1-enyl}-pyridine-2-carboxylic acid, used to treat prostaglandin mediated diseases that include inflammatory, neuropathic or visceral pain
10/27/2005US20050236980 Charge transport compositions and electronic devices made with such compounds
10/27/2005US20050236977 high durability, prepared at low cost; optical output with an extremely high efficiency and a high luminance
10/27/2005US20050236974 Condensed polycyclic compound and organic light-emitting device using the same
10/27/2005CA2563291A1 4-cyano-phenoxy-alkyl carboxyl derivatives as androgen modulators
10/27/2005CA2563225A1 Process for preparing pyridazinone compounds
10/26/2005EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
10/26/2005EP1587786A1 2.4-DIHALOGEN-6-(C sb 2 /sb -C sb 3 /sb -ALKYL)-PHENYL SUBSTITUTED TETRAMIC ACID DERIVATIVES
10/26/2005EP1587621A2 Process for the preparation of a nickel/phosphorous ligand catalyst for olefin hydrocyanation
10/26/2005EP1129071B1 Phenyl-substituted cyclic enaminones
10/26/2005CN1688539A Improved syntheton synthesis
10/26/2005CN1688530A Method for producing partial oxidation products and/or partial ammoxidation products of at least one olefinic hydrocarbon
10/26/2005CN1688527A Fused benzene derivative and use
10/26/2005CN1687021A 1-cyan-1-(3, 5-dimethoxy phenyl)-2-(4-R group phenyl ethane and preparation method
10/26/2005CN1224611C Process for preparing aliphatic trinitrile
10/26/2005CN1224598C Naphthalene derivatives
10/25/2005US6958414 a portion of the reaction gas is brought from a low initial pressure to a higher final pressure by means of a radial compressor; radial compressor tolerates polymer deposits on rotor; acrylic acid from propane
10/25/2005CA2265488C Process for simultaneously preparing 6-aminocapronitrile and hexamethylene diamine
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097719A1 A method for preparing hydroxystyrenes and acetylated derivatives thereof
10/20/2005WO2005097093A1 Sleep inducing compounds and methods relating thereto
10/20/2005US20050234236 Process for preparing pyridazinone compounds
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2005EP1586944A1 Cyanoadamantyl compounds and polymers
10/19/2005EP1586598A1 Process for preparation of polymeric, phosphorus-containing compositions
10/19/2005EP1586377A2 Processes for preparing unsaturated carboxylic acids or their esters using modified mixed oxide catalysts
10/19/2005EP1585745A1 Fc receptor modulating compounds and compositions
10/19/2005EP1585722A2 Method for synthesis of compounds comprising nitrile functions from ethylenically unsaturated compounds
10/19/2005EP1585521A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
10/19/2005CN1684944A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/19/2005CN1223579C Method for preparing p-cholera cyanobenzene
10/19/2005CN1223561C Compound having tetrahydronalphthalene skeleton and liquid crystal composition containing same
10/18/2005US6956988 Optical interleaver
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005US6955837 Phenylcyclohexanes and a liquid-crystalline medium
10/13/2005WO2005095547A1 Propylene hydroformylation
10/13/2005WO2005095333A1 Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl)ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester
10/13/2005WO2005095315A2 Process for hydroformylation of propylene
10/13/2005WO2005094810A2 Novel pharmaceutical compositions
10/13/2005WO2005094506A2 Catalyst composition for the selective conversion of alkanes to unsaturated carboxylic acids, method of making and method of using thereof
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 271